Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Underutilization of local salvage therapy after radiation therapy for prostate cancer.

Tran H, Kwok J, Pickles T, Tyldesley S, Black PC.

Urol Oncol. 2014 Jul;32(5):701-6. doi: 10.1016/j.urolonc.2013.12.014. Epub 2014 Mar 12.

PMID:
24629499
2.

Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.

Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC.

J Urol. 2009 Aug;182(2):517-25; discussion 525-7. doi: 10.1016/j.juro.2009.04.006. Epub 2009 Jun 13.

PMID:
19524984
3.

Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.

Lee HK, Adams MT, Motta J.

Brachytherapy. 2008 Jan-Mar;7(1):17-21. doi: 10.1016/j.brachy.2007.11.002. Epub 2008 Jan 16.

PMID:
18201939
4.

Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.

Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1493-9. doi: 10.1016/j.ijrobp.2011.10.047. Epub 2012 Mar 6.

PMID:
22401922
5.

High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy.

Strom TJ, Wilder RB, Fernandez DC, Mellon EA, Saini AS, Hunt DC, Biagioli MC.

Brachytherapy. 2014 Mar-Apr;13(2):123-7. doi: 10.1016/j.brachy.2013.09.008. Epub 2013 Oct 23.

PMID:
24269146
6.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
7.

Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.

Leonardo C, Simone G, Papalia R, Franco G, Guaglianone S, Gallucci M.

Int J Urol. 2009 Jun;16(6):584-6. doi: 10.1111/j.1442-2042.2008.02209.x. Epub 2009 Apr 22.

8.

Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review.

Peters M, Moman MR, van der Poel HG, Vergunst H, de Jong IJ, Vijverberg PL, Battermann JJ, Horenblas S, van Vulpen M.

World J Urol. 2013 Apr;31(2):403-9. doi: 10.1007/s00345-012-0928-8. Epub 2012 Aug 18. Review.

PMID:
22903773
9.

Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation.

Song C, Kim YS, Hong JH, Kim CS, Ahn H.

BJU Int. 2010 Jul;106(2):188-93. doi: 10.1111/j.1464-410X.2009.09136.x. Epub 2009 Dec 11.

10.

Salvage brachytherapy for localized prostate cancer after radiotherapy failure.

Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, Larson TR, Wilkes MM, Navickis RJ.

Urology. 1999 Jan;53(1):2-10.

PMID:
9886580
11.

Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.

Tiguert R, Rigaud J, Lacombe L, Laverdière J, Fradet Y.

J Urol. 2003 Aug;170(2 Pt 1):447-50.

PMID:
12853796
12.

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Créhange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT.

Cancer Radiother. 2014 Oct;18(5-6):524-34. doi: 10.1016/j.canrad.2014.07.153. Epub 2014 Sep 2. Review. Erratum in: Cancer Radiother. 2014 Dec;18(8):806.

PMID:
25192626
13.

Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.

Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y, Ito K, Kiriu H, Ito A.

Int J Clin Oncol. 2007 Feb;12(1):37-41. Epub 2007 Feb 25.

PMID:
17380439
14.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

15.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
16.

Current status of local salvage therapies following radiation failure for prostate cancer.

Touma NJ, Izawa JI, Chin JL.

J Urol. 2005 Feb;173(2):373-9. Review.

PMID:
15643174
17.

Salvage therapy for locally recurrent prostate cancer after radiation.

Marcus DM, Canter DJ, Jani AB, Dobbs RW, Schuster DM, Carthon BC, Rossi PJ.

Can J Urol. 2012 Dec;19(6):6534-41. Review.

PMID:
23228288
18.

Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.

Vaidya A, Soloway MS.

J Urol. 2000 Dec;164(6):1998-2001.

PMID:
11061900
19.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
20.

Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.

Henríquez I, Sancho G, Hervás A, Guix B, Pera J, Gutierrez C, Abuchaibe O, Martínez-Monge R, Tormo A, Polo A.

Radiat Oncol. 2014 Apr 30;9:102. doi: 10.1186/1748-717X-9-102.

Supplemental Content

Support Center